Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))

P. Jain; J. Gutierrez Bugarin; A. Guha; C. Jain; N. Patil; T. Shen; I. Stanevich; V. Nikore; K. Margolin; M. Ernstoff; V. Velcheti; J. Barnholtz-Sloan; A. Dowlati

doi:10.1016/j.esmoop.2021.100286

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))

P. Jain, J. Gutierrez Bugarin, A. Guha, C. Jain, N. Patil, T. Shen, I. Stanevich, V. Nikore, K. Margolin, M. Ernstoff, V. Velcheti, J. Barnholtz-Sloan, A. Dowlati

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Abstract

The authors regret that at the time the article was published there were some minor errors which have now been corrected. In the introduction the sentence “ICIs act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” has been corrected to “Immune checkpoints act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” In Figure 2 a label was corrected to irAE as per the below. The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	100286
Journal	ESMO Open
Volume	6
Issue number	6
DOIs	https://doi.org/10.1016/j.esmoop.2021.100286
State	Published - Dec 2021

Access to Document

10.1016/j.esmoop.2021.100286

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))'. Together they form a unique fingerprint.

Cite this

Jain, P., Gutierrez Bugarin, J., Guha, A., Jain, C., Patil, N., Shen, T., Stanevich, I., Nikore, V., Margolin, K., Ernstoff, M., Velcheti, V., Barnholtz-Sloan, J., & Dowlati, A. (2021). Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252)). ESMO Open, 6(6), Article 100286. https://doi.org/10.1016/j.esmoop.2021.100286

Jain, P. ; Gutierrez Bugarin, J. ; Guha, A. et al. / Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’ : [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252)). In: ESMO Open. 2021 ; Vol. 6, No. 6.

@article{8b8914967a3047eb9a210bfbc35f9985,

title = "Corrigendum to {\textquoteleft}Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States{\textquoteright}: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))",

abstract = "The authors regret that at the time the article was published there were some minor errors which have now been corrected. In the introduction the sentence “ICIs act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” has been corrected to “Immune checkpoints act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” In Figure 2 a label was corrected to irAE as per the below. The authors would like to apologise for any inconvenience caused.",

author = "P. Jain and {Gutierrez Bugarin}, J. and A. Guha and C. Jain and N. Patil and T. Shen and I. Stanevich and V. Nikore and K. Margolin and M. Ernstoff and V. Velcheti and J. Barnholtz-Sloan and A. Dowlati",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = dec,

doi = "10.1016/j.esmoop.2021.100286",

language = "English",

volume = "6",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "Elsevier B.V.",

number = "6",

}

Jain, P, Gutierrez Bugarin, J, Guha, A, Jain, C, Patil, N, Shen, T, Stanevich, I, Nikore, V, Margolin, K, Ernstoff, M, Velcheti, V, Barnholtz-Sloan, J & Dowlati, A 2021, 'Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))', ESMO Open, vol. 6, no. 6, 100286. https://doi.org/10.1016/j.esmoop.2021.100286

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252)). / Jain, P.; Gutierrez Bugarin, J.; Guha, A. et al.
In: ESMO Open, Vol. 6, No. 6, 100286, 12.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

T2 - [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))

AU - Jain, P.

AU - Gutierrez Bugarin, J.

AU - Guha, A.

AU - Jain, C.

AU - Patil, N.

AU - Shen, T.

AU - Stanevich, I.

AU - Nikore, V.

AU - Margolin, K.

AU - Ernstoff, M.

AU - Velcheti, V.

AU - Barnholtz-Sloan, J.

AU - Dowlati, A.

PY - 2021/12

Y1 - 2021/12

N2 - The authors regret that at the time the article was published there were some minor errors which have now been corrected. In the introduction the sentence “ICIs act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” has been corrected to “Immune checkpoints act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” In Figure 2 a label was corrected to irAE as per the below. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that at the time the article was published there were some minor errors which have now been corrected. In the introduction the sentence “ICIs act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” has been corrected to “Immune checkpoints act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” In Figure 2 a label was corrected to irAE as per the below. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85120322675&partnerID=8YFLogxK

U2 - 10.1016/j.esmoop.2021.100286

DO - 10.1016/j.esmoop.2021.100286

M3 - Comment/debate

C2 - 34678570

AN - SCOPUS:85120322675

SN - 2059-7029

VL - 6

JO - ESMO Open

JF - ESMO Open

IS - 6

M1 - 100286

ER -

Jain P, Gutierrez Bugarin J, Guha A, Jain C, Patil N, Shen T et al. Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252)). ESMO Open. 2021 Dec;6(6):100286. doi: 10.1016/j.esmoop.2021.100286

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this